<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36898766</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus.</ArticleTitle><Pagination><StartPage>646</StartPage><EndPage>657</EndPage><MedlinePgn>646-657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/ard-2022-223506</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Inflammatory mediators are detected in the cerebrospinal fluid of systemic lupus erythematosus patients with central nervous system involvement (NPSLE), yet the underlying cellular and molecular mechanisms leading to neuropsychiatric disease remain elusive.</AbstractText><AbstractText Label="METHODS">We performed a comprehensive phenotyping of NZB/W-F1 lupus-prone mice including tests for depression, anxiety and cognition. Immunofluorescence, flow cytometry, RNA-sequencing, qPCR, cytokine quantification and blood-brain barrier (BBB) permeability assays were applied in hippocampal tissue obtained in both prenephritic (3-month-old) and nephritic (6-month-old) lupus mice and matched control strains. Healthy adult hippocampal neural stem cells (hiNSCs) were exposed <i>ex vivo</i> to exogenous inflammatory cytokines to assess their effects on proliferation and apoptosis.</AbstractText><AbstractText Label="RESULTS">At the prenephritic stage, BBB is intact yet mice exhibit hippocampus-related behavioural deficits recapitulating the human diffuse neuropsychiatric disease. This phenotype is accounted by disrupted hippocampal neurogenesis with hiNSCs exhibiting increased proliferation combined with decreased differentiation and increased apoptosis in combination with microglia activation and increased secretion of proinflammatory cytokines and chemokines. Among these cytokines, IL-6 and IL-18 directly induce apoptosis of adult hiNSCs ex vivo. During the nephritic stage, BBB becomes disrupted which facilitates immune components of peripheral blood, particularly B-cells, to penetrate into the hippocampus further augmenting inflammation with locally increased levels of IL-6, IL-12, IL-18 and IL-23. Of note, an interferon gene signature was observed only at nephritic-stage.</AbstractText><AbstractText Label="CONCLUSION">An intact BBB with microglial activation disrupting the formation of new neurons within the hippocampus represent early events in NPSLE. Disturbances of the BBB and interferon signature are evident later in the course of the disease.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nikolopoulos</LastName><ForeName>Dionysis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9894-6966</Identifier><AffiliationInfo><Affiliation>Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece dsnikolopoulos@gmail.com boumpasd@uoc.gr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manolakou</LastName><ForeName>Theodora</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5284-6655</Identifier><AffiliationInfo><Affiliation>Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polissidis</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biomedical Research Foundation of the Academy, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filia</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertsias</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology, Clinical Immunology and Allergy Department, Medical School University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutmani</LastName><ForeName>Yassemi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biomedical Research Foundation of the Academy, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boumpas</LastName><ForeName>Dimitrios T</ForeName><Initials>DT</Initials><Identifier Source="ORCID">0000-0002-9812-4671</Identifier><AffiliationInfo><Affiliation>Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece dsnikolopoulos@gmail.com boumpasd@uoc.gr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020382">Interleukin-18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020382" MajorTopicYN="N">Interleukin-18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055495" MajorTopicYN="N">Neurogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Lupus Erythematosus, Systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36898766</ArticleId><ArticleId IdType="pmc">PMC10176423</ArticleId><ArticleId IdType="doi">10.1136/ard-2022-223506</ArticleId><ArticleId IdType="pii">ard-2022-223506</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nikolopoulos D, Kostopoulou M, Pieta A, et al. . Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the &#x201c; Attikon &#x201d; cohort. Lupus 2020;29:514&#x2013;22. 10.1177/0961203320908932</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320908932</ArticleId><ArticleId IdType="pmc">PMC7168806</ArticleId><ArticleId IdType="pubmed">32106788</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos D, Fanouriakis A, Bertsias G. Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives. Expert Rev Clin Immunol 2021;17:317&#x2013;30. 10.1080/1744666X.2021.1899810</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1899810</ArticleId><ArticleId IdType="pubmed">33682602</ArticleId></ArticleIdList></Reference><Reference><Citation>MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 2011;16:252&#x2013;64. 10.1038/mp.2010.80</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2010.80</ArticleId><ArticleId IdType="pubmed">20661246</ArticleId></ArticleIdList></Reference><Reference><Citation>Small SA, Schobel SA, Buxton RB, et al. . A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 2011;12:585&#x2013;601. 10.1038/nrn3085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3085</ArticleId><ArticleId IdType="pmc">PMC3312472</ArticleId><ArticleId IdType="pubmed">21897434</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGiorgio LA, Konstantinov KN, Lee SC, et al. . A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189&#x2013;93. 10.1038/nm1101-1189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1101-1189</ArticleId><ArticleId IdType="pubmed">11689882</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerta PT, Kowal C, DeGiorgio LA, et al. . Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006;103:678&#x2013;83. 10.1073/pnas.0510055103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510055103</ArticleId><ArticleId IdType="pmc">PMC1334673</ArticleId><ArticleId IdType="pubmed">16407105</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestor J, Arinuma Y, Huerta TS, et al. . Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J Exp Med 2018;215:2554&#x2013;66. 10.1084/jem.20180776</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180776</ArticleId><ArticleId IdType="pmc">PMC6170183</ArticleId><ArticleId IdType="pubmed">30185634</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust TW, Chang EH, Kowal C, et al. . Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A 2010;107:18569&#x2013;74. 10.1073/pnas.1006980107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006980107</ArticleId><ArticleId IdType="pmc">PMC2972998</ArticleId><ArticleId IdType="pubmed">20921396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay M, Tang CC, Volpe BT, et al. . Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus. Lupus Sci Med 2015;2:e000074. 10.1136/lupus-2014-000074</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000074</ArticleId><ArticleId IdType="pmc">PMC4379887</ArticleId><ArticleId IdType="pubmed">25861456</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Cheng Y, Zhao Y, et al. . Hippocampal atrophy in systemic lupus erythematosus patients without major neuropsychiatric manifestations. J Immunol Res 2020;2020:2943848. 10.1155/2020/2943848</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2943848</ArticleId><ArticleId IdType="pmc">PMC7306071</ArticleId><ArticleId IdType="pubmed">32626787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempermann G, Song H, Gage FH. Neurogenesis in the adult hippocampus. Cold Spring Harb Perspect Biol 2015;7:a018812. 10.1101/cshperspect.a018812</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018812</ArticleId><ArticleId IdType="pmc">PMC4563705</ArticleId><ArticleId IdType="pubmed">26330519</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalding KL, Bergmann O, Alkass K, et al. . Dynamics of hippocampal neurogenesis in adult humans. Cell 2013;153:1219&#x2013;27.:1219. 10.1016/j.cell.2013.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.05.002</ArticleId><ArticleId IdType="pmc">PMC4394608</ArticleId><ArticleId IdType="pubmed">23746839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann O, Spalding KL, Fris&#xe9;n J. Adult neurogenesis in humans. Cold Spring Harb Perspect Biol 2015;7:a018994. 10.1101/cshperspect.a018994</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018994</ArticleId><ArticleId IdType="pmc">PMC4484963</ArticleId><ArticleId IdType="pubmed">26134318</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965;124:319&#x2013;35. 10.1002/cne.901240303</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.901240303</ArticleId><ArticleId IdType="pubmed">5861717</ArticleId></ArticleIdList></Reference><Reference><Citation>Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility-linking memory and mood. Nat Rev Neurosci 2017;18:335&#x2013;46. 10.1038/nrn.2017.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.45</ArticleId><ArticleId IdType="pmc">PMC6261347</ArticleId><ArticleId IdType="pubmed">28469276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, Jinnou H, Sawamoto K, et al. . Adult neurogenesis and its role in brain injury and psychiatric diseases. J Neurochem 2018;147:584&#x2013;94. 10.1111/jnc.14557</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14557</ArticleId><ArticleId IdType="pubmed">30028510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Hu Q, Madri JA, et al. . Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A 1996;93:8563&#x2013;8. 10.1073/pnas.93.16.8563</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.16.8563</ArticleId><ArticleId IdType="pmc">PMC38712</ArticleId><ArticleId IdType="pubmed">8710910</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoriou M, Banos A, Filia A, et al. . Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus. Ann Rheum Dis 2020;79:242&#x2013;53. 10.1136/annrheumdis-2019-215782</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215782</ArticleId><ArticleId IdType="pmc">PMC7025734</ArticleId><ArticleId IdType="pubmed">31780527</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutmani Y, Gampierakis IA, Polissidis A, et al. . Crh promotes the neurogenic activity of neural stem cells in the adult hippocampus. Cell Rep 2019;29:932&#x2013;945.S2211-1247(19)31225-2. 10.1016/j.celrep.2019.09.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.037</ArticleId><ArticleId IdType="pubmed">31644914</ArticleId></ArticleIdList></Reference><Reference><Citation>Polissidis A, Zelelak S, Nikita M, et al. . Assessing the exploratory and anxiety-related behaviors of mice. do different caging systems affect the outcome of behavioral tests? Physiol Behav 2017;177:68&#x2013;73.:S0031-9384(17)30101-4. 10.1016/j.physbeh.2017.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2017.04.009</ArticleId><ArticleId IdType="pubmed">28412281</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampetsou M, Ardah MT, Semitekolou M, et al. . Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci Rep 2017;7:16533.:16533. 10.1038/s41598-017-15813-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15813-8</ArticleId><ArticleId IdType="pmc">PMC5705684</ArticleId><ArticleId IdType="pubmed">29184069</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangra A, Rajput P, Dwivedi DK, et al. . Amelioration of repeated restraint stress-induced behavioral deficits and hippocampal anomalies with taurine treatment in mice. Neurochem Res 2020;45:731&#x2013;40. 10.1007/s11064-019-02945-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-019-02945-8</ArticleId><ArticleId IdType="pubmed">31898086</ArticleId></ArticleIdList></Reference><Reference><Citation>Sichler ME, L&#xf6;w MJ, Schleicher EM, et al. . Reduced acoustic startle response and prepulse inhibition in the tg4-42 model of Alzheimer&#x2019;s disease. J Alzheimers Dis Rep 2019;3:269&#x2013;78. 10.3233/ADR-190132</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-190132</ArticleId><ArticleId IdType="pmc">PMC6918877</ArticleId><ArticleId IdType="pubmed">31867566</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy SS, Nadler JJ, Perez A, et al. . Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004;3:287&#x2013;302. 10.1111/j.1601-1848.2004.00076.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1601-1848.2004.00076.x</ArticleId><ArticleId IdType="pubmed">15344922</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M-Y, Yin C-Y, Zhu L-J, et al. . Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 2018;13:1686&#x2013;98. 10.1038/s41596-018-0011-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-018-0011-z</ArticleId><ArticleId IdType="pubmed">29988104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoupri E, Kostavasili I, Kloukina I, et al. . Myospryn deficiency leads to impaired cardiac structure and function and schizophrenia-associated symptoms. Cell Tissue Res 2021;385:675&#x2013;96. 10.1007/s00441-021-03447-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-021-03447-2</ArticleId><ArticleId IdType="pubmed">34037836</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K, McColl BW. Isolation and phenotyping of adult mouse microglial cells. Methods Mol Biol 2018;1784:77&#x2013;86. 10.1007/978-1-4939-7837-3_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7837-3_7</ArticleId><ArticleId IdType="pubmed">29761389</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolakou T, Nikolopoulos D, Gkikas D, et al. . ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus. Sci Adv 2022;8:eabo5840. 10.1126/sciadv.abo5840</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abo5840</ArticleId><ArticleId IdType="pmc">PMC9616496</ArticleId><ArticleId IdType="pubmed">36306362</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;&#xdf; P, Hoffmann A, Rothe T, et al. . Chronic peripheral inflammation causes a region-specific myeloid response in the central nervous system. Cell Rep 2020;30:4082&#x2013;95.:S2211-1247(20)30290-4. 10.1016/j.celrep.2020.02.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.109</ArticleId><ArticleId IdType="pubmed">32209470</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AR, Kim JH, Cho E, et al. . Dorsal and ventral hippocampus differentiate in functional pathways and differentially associate with neurological disease-related genes during postnatal development. Front Mol Neurosci 2017;10:331. 10.3389/fnmol.2017.00331</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00331</ArticleId><ArticleId IdType="pmc">PMC5650623</ArticleId><ArticleId IdType="pubmed">29085281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopperton KE, Mohammad D, Tr&#xe9;panier MO, et al. . Markers of microglia in post-mortem brain samples from patients with Alzheimer&#x2019;s disease: a systematic review. Mol Psychiatry 2018;23:177&#x2013;98. 10.1038/mp.2017.246</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2017.246</ArticleId><ArticleId IdType="pmc">PMC5794890</ArticleId><ArticleId IdType="pubmed">29230021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 2016;53:1181&#x2013;94. 10.1007/s12035-014-9070-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, et al. . Neuroinflammation: microglia and T cells get ready to tango. Front Immunol 2017;8:1905. 10.3389/fimmu.2017.01905</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01905</ArticleId><ArticleId IdType="pmc">PMC5788906</ArticleId><ArticleId IdType="pubmed">29422891</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien CH, Lee MJ, Liou HC, et al. . Microglia-derived cytokines/chemokines are involved in the enhancement of LPS-induced loss of nigrostriatal dopaminergic neurons in DJ-1 knockout mice. PLoS One 2016;11:e0151569. 10.1371/journal.pone.0151569</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151569</ArticleId><ArticleId IdType="pmc">PMC4794203</ArticleId><ArticleId IdType="pubmed">26982707</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos D, Fanouriakis A, Boumpas DT. Update on the pathogenesis of central nervous system lupus. Curr Opin Rheumatol 2019;31:669&#x2013;77. 10.1097/BOR.0000000000000655</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000655</ArticleId><ArticleId IdType="pubmed">31415031</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoury L, Zarfeshani A, Diamond B. Using the mouse to model human diseases: cognitive impairment in systemic lupus erythematosus. J Rheumatol 2020;47:1145&#x2013;9. 10.3899/jrheum.200410</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200410</ArticleId><ArticleId IdType="pubmed">32295852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev 2014;13:963&#x2013;73.:S1568-9972(14)00159-1. 10.1016/j.autrev.2014.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.08.015</ArticleId><ArticleId IdType="pubmed">25183233</ArticleId></ArticleIdList></Reference><Reference><Citation>Stock AD, Der E, Gelb S, et al. . Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus. JCI Insight 2019;4:1&#x2013;16.:e124203. 10.1172/jci.insight.124203</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.124203</ArticleId><ArticleId IdType="pmc">PMC6629135</ArticleId><ArticleId IdType="pubmed">31167973</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore E, Huang MW, Reynolds CA, et al. . Choroid plexus-infiltrating T cells as drivers of murine neuropsychiatric lupus. Arthritis Rheumatol 2022;74:1796&#x2013;807. 10.1002/art.42252</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42252</ArticleId><ArticleId IdType="pmc">PMC9825865</ArticleId><ArticleId IdType="pubmed">35637551</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanarsa K, Sasidharan P, Duran V, et al. . Aptamer-Based screen of neuropsychiatric lupus cerebrospinal fluid reveals potential biomarkers that overlap with the choroid plexus transcriptome. Arthritis Rheumatol 2022;74:1223&#x2013;34. 10.1002/art.42080</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42080</ArticleId><ArticleId IdType="pubmed">35099126</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal C, Diamond B. Aspects of CNS lupus: mouse models of anti-NMDA receptor antibody mediated reactivity. Methods Mol Biol 2012;900:181&#x2013;206. 10.1007/978-1-60761-720-4_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-720-4_9</ArticleId><ArticleId IdType="pubmed">22933070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng D, Liu Y, Sidobre S, et al. . Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest 2003;112:1211&#x2013;22. 10.1172/JCI17165</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI17165</ArticleId><ArticleId IdType="pmc">PMC213484</ArticleId><ArticleId IdType="pubmed">14561706</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Titov AA, Morel L. An update on lupus animal models. Curr Opin Rheumatol 2017;29:434&#x2013;41. 10.1097/BOR.0000000000000412</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000412</ArticleId><ArticleId IdType="pmc">PMC5815391</ArticleId><ArticleId IdType="pubmed">28537986</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Xu T, Ding C, et al. . Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus. Signal Transduct Target Ther 2022;7:50.:50. 10.1038/s41392-021-00867-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00867-y</ArticleId><ArticleId IdType="pmc">PMC8854434</ArticleId><ArticleId IdType="pubmed">35177587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Liu X, Fu J, et al. . STREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K-Akt signaling pathway. Sci Rep 2022;12:7047.:7047. 10.1038/s41598-022-10973-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10973-8</ArticleId><ArticleId IdType="pmc">PMC9054830</ArticleId><ArticleId IdType="pubmed">35487953</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruwaka K, Ikegami A, Tachibana Y, et al. . Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 2019;10:5816.:5816. 10.1038/s41467-019-13812-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13812-z</ArticleId><ArticleId IdType="pmc">PMC6925219</ArticleId><ArticleId IdType="pubmed">31862977</ArticleId></ArticleIdList></Reference><Reference><Citation>Panousis NI, Bertsias GK, Ongen H, et al. . Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis 2019;78:1079&#x2013;89. 10.1136/annrheumdis-2018-214379</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214379</ArticleId><ArticleId IdType="pmc">PMC6691930</ArticleId><ArticleId IdType="pubmed">31167757</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A, Zunszain PA, Thuret S, et al. . The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci 2015;38:145&#x2013;57.:S0166-2236(14)00234-3. 10.1016/j.tins.2014.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2014.12.006</ArticleId><ArticleId IdType="pubmed">25579391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gampierakis I-A, Koutmani Y, Semitekolou M, et al. . Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD). Mol Psychiatry 2021;26:1248&#x2013;63. 10.1038/s41380-020-0651-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0651-6</ArticleId><ArticleId IdType="pubmed">31969694</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakopoulou A, Grigoriadis N, Bekiari C, et al. . Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model. J Neurosci Res 2013;91:890&#x2013;900. 10.1002/jnr.23226</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23226</ArticleId><ArticleId IdType="pubmed">23606574</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakopoulou A, Lyras GA, Grigoriadis N. Long-Term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis. J Neurosci Res 2017;95:1446&#x2013;58. 10.1002/jnr.23982</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23982</ArticleId><ArticleId IdType="pubmed">27781303</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson KME, Was&#xe9;n C, Juzokaite L, et al. . Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis. Proc Natl Acad Sci U S A 2018;115:E12063&#x2013;72. 10.1073/pnas.1810553115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810553115</ArticleId><ArticleId IdType="pmc">PMC6305002</ArticleId><ArticleId IdType="pubmed">30509997</ArticleId></ArticleIdList></Reference><Reference><Citation>Crupi R, Cambiaghi M, Spatz L, et al. . Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice. Biol Psychiatry 2010;67:558&#x2013;66. 10.1016/j.biopsych.2009.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.12.008</ArticleId><ArticleId IdType="pubmed">20185032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruszn&#xe1;k K, Horv&#xe1;th &#xc1;I, Pohli-T&#xf3;th K, et al. . Experimental arthritis inhibits adult hippocampal neurogenesis in mice. Cells 2022;11:1&#x2013;26.:791. 10.3390/cells11050791</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11050791</ArticleId><ArticleId IdType="pmc">PMC8909078</ArticleId><ArticleId IdType="pubmed">35269413</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojcic M, Burstyn-Cohen T, Nashi N, et al. . Disturbed distribution of proliferative brain cells during lupus-like disease. Brain Behav Immun 2009;23:1003&#x2013;13. 10.1016/j.bbi.2009.05.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2009.05.061</ArticleId><ArticleId IdType="pmc">PMC2894939</ArticleId><ArticleId IdType="pubmed">19501646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33:644&#x2013;9. 10.1002/art.1780330506</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780330506</ArticleId><ArticleId IdType="pubmed">2346520</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang R, Zheng L, Ji T, et al. . Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders. Lupus 2022;31:187&#x2013;93. 10.1177/09612033211069853</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211069853</ArticleId><ArticleId IdType="pubmed">35042378</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore MRP, Najafi AR, Koike MA, et al. . Colony-Stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 2014;82:380&#x2013;97.:S0896-6273(14)00171-8. 10.1016/j.neuron.2014.02.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.02.040</ArticleId><ArticleId IdType="pmc">PMC4161285</ArticleId><ArticleId IdType="pubmed">24742461</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xfc;lle L, Offermann N, Hansen JN, et al. . Ccl17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons. Glia 2018;66:2246&#x2013;61. 10.1002/glia.23507</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23507</ArticleId><ArticleId IdType="pubmed">30277599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruland C, Renken H, Kuzmanov I, et al. . Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain Behav Immun 2017;66:382&#x2013;93.:S0889-1591(17)30199-X. 10.1016/j.bbi.2017.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.06.010</ArticleId><ArticleId IdType="pubmed">28642092</ArticleId></ArticleIdList></Reference><Reference><Citation>Columba-Cabezas S, Serafini B, Ambrosini E, et al. . Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J Neuroimmunol 2002;130:10&#x2013;21. 10.1016/s0165-5728(02)00170-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(02)00170-4</ArticleId><ArticleId IdType="pubmed">12225884</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JJ, Marro BS, Skinner DD, et al. . Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. Eur J Immunol 2018;48:1199&#x2013;210. 10.1002/eji.201747442</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201747442</ArticleId><ArticleId IdType="pmc">PMC6033633</ArticleId><ArticleId IdType="pubmed">29697856</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny MF, Thacker S, Mehta H, et al. . Interferon-Alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007;110:2907&#x2013;15. 10.1182/blood-2007-05-089086</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-05-089086</ArticleId><ArticleId IdType="pmc">PMC2018671</ArticleId><ArticleId IdType="pubmed">17638846</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachholz S, E&#xdf;linger M, Pl&#xfc;mper J, et al. . Microglia activation is associated with IFN-&#x3b1; induced depressive-like behavior. Brain Behav Immun 2016;55:105&#x2013;13.:S0889-1591(15)30023-4. 10.1016/j.bbi.2015.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.016</ArticleId><ArticleId IdType="pubmed">26408795</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Hou X, Feng Q, et al. . Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor. J Transl Med 2019;17:426.:426. 10.1186/s12967-019-02175-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02175-0</ArticleId><ArticleId IdType="pmc">PMC6925475</ArticleId><ArticleId IdType="pubmed">31864410</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Davidson A. Ifn&#x3b1; inducible models of murine SLE. Front Immunol 2013;4:306.:306. 10.3389/fimmu.2013.00306</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00306</ArticleId><ArticleId IdType="pmc">PMC3788378</ArticleId><ArticleId IdType="pubmed">24106491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocito C, Lubinsky C, Hand M, et al. . Centrally acting angiotensin-converting enzyme inhibitor suppresses type I interferon responses and decreases inflammation in the periphery and the CNS in lupus-prone mice. Front Immunol 2020;11:573677. 10.3389/fimmu.2020.573677</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.573677</ArticleId><ArticleId IdType="pmc">PMC7522287</ArticleId><ArticleId IdType="pubmed">33042154</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centrally acting ACE inhibition in SLE - full text view - clinicaltrials.gov. Available: https://clinicaltrials.gov/ct2/show/NCT04486118?term=ace+inhibitor&amp;cond=lupus&amp;draw=2&amp;rank=1 [Accessed 8 Oct 2022].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>